chevron_leftBack
As of 24 April 2025, Procter & Gamble Health Ltd. has a market cap of $1.0B USD, ranking #8152 globally and #557 in India. It ranks #788 in the Healthcare sector, and #180 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$1.0BUSD
85.73B INR
Enterprise Value
$971.75MUSD
83.08B INR
Revenue (TTM)
$135.89MUSD
11.6B INR
EBITDA (TTM)
$41.0MUSD
3.51B INR
Net Income (TTM)
$27.72MUSD
2.37B INR
EBITDA Margin
30%
Profit Margin
20%
PE Ratio
36.2
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Milind Thatte
open_in_new
Employees
1,336
Founded
1967
Website
pghealthindia.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.4% | -1.2% | -6.1% | -5.8% | 0.1% | 10% |
Upcoming Earnings
Earnings Date
Thu, May 29
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
PGHL
Procter & Gamble Health Ltd
ISIN: INE199A01012
Shares Out.:
Shares Outstanding:
16.599M1
Shares Float:
7.936M2
|
5.24K INR | |
|
500126
(PGHL)
Procter & Gamble Health Ltd
ISIN: INE199A01012
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
5.23K INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Procter & Gamble Health Ltd.
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.
